澳大利亚儿童在放松针对 SARS-COV-2 的非药物干预措施后侵袭性肺炎球菌病的临床和流行病学特征。
Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS-COV-2.
机构信息
From the National Centre for Immunisation Research and Surveillance, New South Wales, Australia.
School of Public Health, Faculty of Medicine, The University of Sydney, New South Wales, Australia.
出版信息
Pediatr Infect Dis J. 2023 Sep 1;42(9):e341-e342. doi: 10.1097/INF.0000000000003972. Epub 2023 May 18.
Abstract
A global resurgence of invasive pneumococcal disease (IPD) has been noted in children. We provide a detailed clinical and epidemiological analysis of IPD in Australian children following relaxation of nonpharmaceutical interventions against coronavirus disease 2019, revealing significant morbidity and mortality-even in vaccinated children without known predisposing risk factors. Almost half of the IPD cases were caused by serotypes not covered by the 13-valent pneumococcal conjugate vaccine.
摘要
全球侵袭性肺炎球菌病（IPD）在儿童中再次出现。我们详细分析了澳大利亚儿童在放松针对 2019 年冠状病毒病的非药物干预措施后的 IPD 情况，结果显示即使是接种疫苗且无已知易感危险因素的儿童，发病率和死亡率仍很高。几乎一半的 IPD 病例是由 13 价肺炎球菌结合疫苗未覆盖的血清型引起的。
相似文献
1
Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS-COV-2.澳大利亚儿童在放松针对 SARS-COV-2 的非药物干预措施后侵袭性肺炎球菌病的临床和流行病学特征。
Pediatr Infect Dis J. 2023 Sep 1;42(9):e341-e342. doi: 10.1097/INF.0000000000003972. Epub 2023 May 18.
2
Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.澳大利亚 2002-2014 年 7 价和 13 价肺炎球菌结合疫苗“3+0”免疫程序对侵袭性肺炎球菌病的长期影响
Clin Infect Dis. 2017 Jan 15;64(2):175-183. doi: 10.1093/cid/ciw720. Epub 2016 Oct 21.
3
4
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children.儿童高价肺炎球菌结合疫苗预防侵袭性肺炎球菌病失败和突破性疾病的系统评价
Expert Rev Vaccines. 2022 Feb;21(2):201-214. doi: 10.1080/14760584.2022.2012455. Epub 2022 Feb 3.
5
Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.2001年至2002年澳大利亚侵袭性肺炎球菌疾病的实验室监测——对疫苗血清型覆盖率的影响。
Commun Dis Intell Q Rep. 2003;27(4):478-87.
6
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.评估7价肺炎球菌结合疫苗接种后23价肺炎球菌多糖疫苗对澳大利亚原住民儿童的影响。
Vaccine. 2015 Nov 27;33(48):6666-74. doi: 10.1016/j.vaccine.2015.10.089. Epub 2015 Oct 29.
7
Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.魁北克使用三种不同肺炎球菌结合疫苗前后侵袭性肺炎球菌病的发病情况。
Vaccine. 2018 Jan 8;36(3):421-426. doi: 10.1016/j.vaccine.2017.11.054. Epub 2017 Dec 7.
8
Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain.COVID-19 大流行对西班牙加泰罗尼亚儿童侵袭性肺炎球菌病的影响。
Emerg Infect Dis. 2022 Nov;28(11):2321-2325. doi: 10.3201/eid2811.211741. Epub 2022 Oct 11.
9
Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine.台湾实施13价肺炎球菌结合疫苗全国补种计划后的儿童侵袭性肺炎球菌疾病
Pediatr Infect Dis J. 2015 Mar;34(3):e71-7. doi: 10.1097/INF.0000000000000565.
10
Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States.在美国儿童中，15 价肺炎球菌结合疫苗血清型相关的健康和经济负担。
J Med Econ. 2020 Dec;23(12):1653-1660. doi: 10.1080/13696998.2020.1840216. Epub 2020 Nov 5.
引用本文的文献
1
Serotype 3 invasive pneumococcal disease in Tuscany across the eras of conjugate vaccines (2005-2024) and anthropic-driven respiratory virus fluctuations.托斯卡纳地区在结合疫苗时代（2005 - 2024年）及人为因素驱动的呼吸道病毒波动情况下的3型侵袭性肺炎球菌疾病
Hum Vaccin Immunother. 2025 Dec;21(1):2510005. doi: 10.1080/21645515.2025.2510005. Epub 2025 Jun 17.
2
Update on the evolving landscape of pneumococcal capsule types: new discoveries and way forward.肺炎球菌荚膜类型不断演变的格局最新进展：新发现与未来方向
Clin Microbiol Rev. 2025 Mar 13;38(1):e0017524. doi: 10.1128/cmr.00175-24. Epub 2025 Jan 29.
3
Trends in Hospitalisations for Vaccine Preventable Respiratory Infections Following Emergency Department Presentations in New South Wales, Australia, 2012-2022.澳大利亚新南威尔士州 2012-2022 年急诊科就诊后疫苗可预防呼吸道感染住院趋势。
Influenza Other Respir Viruses. 2024 Oct;18(10):e70015. doi: 10.1111/irv.70015.
4
Severe Invasive Pneumococcal Disease Caused by Serotype 19A in Children Under Five Years in Tāmaki Makaurau Auckland, Aotearoa New Zealand.新西兰奥克兰塔玛基·马考劳五岁以下儿童中由19A血清型引起的严重侵袭性肺炎球菌疾病
Pediatr Infect Dis J. 2025 Jan 1;44(1):90-96. doi: 10.1097/INF.0000000000004528. Epub 2024 Sep 11.
本文引用的文献
1
Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.新型冠状病毒肺炎大流行期间非药物干预措施与法国儿童侵袭性肺炎球菌病、肺炎球菌携带和呼吸道病毒感染的相关性。
JAMA Netw Open. 2022 Jun 1;5(6):e2218959. doi: 10.1001/jamanetworkopen.2022.18959.
2
Off-season RSV epidemics in Australia after easing of COVID-19 restrictions.澳大利亚放宽 COVID-19 限制后出现淡季呼吸道合胞病毒流行。
Nat Commun. 2022 May 24;13(1):2884. doi: 10.1038/s41467-022-30485-3.
3
Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021.2021 年春夏德国侵袭性肺炎球菌病再现。
Clin Infect Dis. 2022 Sep 30;75(7):1149-1153. doi: 10.1093/cid/ciac100.
4
Infant Pneumococcal Carriage in Belgium Not Affected by COVID-19 Containment Measures.比利时婴幼儿肺炎球菌带菌情况不受新冠防控措施影响。
Front Cell Infect Microbiol. 2022 Jan 17;11:825427. doi: 10.3389/fcimb.2021.825427. eCollection 2021.
5
Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.两种新型肺炎球菌疫苗——沛儿20和沃克新。
JAMA. 2021 Dec 28;326(24):2521-2522. doi: 10.1001/jama.2021.22119.
6
Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.在 COVID-19 大流行期间，以色列儿童中肺炎球菌病的减少与季节性呼吸道病毒的抑制有关，尽管肺炎球菌持续传播：一项前瞻性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e1154-e1164. doi: 10.1093/cid/ciab1014.
7
Routine Vaccination Coverage - Worldwide, 2020.常规疫苗接种覆盖率-全球，2020 年。
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1495-1500. doi: 10.15585/mmwr.mm7043a1.
8
Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?儿科传染病专家组（GPIP）关于 COVID-19 大流行期间儿童免疫债的立场文件，我们如何填补免疫差距？
Infect Dis Now. 2021 Aug;51(5):418-423. doi: 10.1016/j.idnow.2021.05.004. Epub 2021 May 12.
9
Impact of Coronavirus Disease 2019 Public Health Measures on Detections of Influenza and Respiratory Syncytial Virus in Children During the 2020 Australian Winter.2020 年澳大利亚冬季，新型冠状病毒病公共卫生措施对儿童流感和呼吸道合胞病毒检测的影响。
Clin Infect Dis. 2021 Jun 15;72(12):2199-2202. doi: 10.1093/cid/ciaa1475.
10
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.2016 年全球 195 个国家/地区下呼吸道感染的发病率、死亡率和病因的全球、区域和国家估计值：2016 年全球疾病负担研究的系统分析。
Lancet Infect Dis. 2018 Nov;18(11):1191-1210. doi: 10.1016/S1473-3099(18)30310-4. Epub 2018 Sep 19.
Zotero 插件